Skip to main content
Log in

Development of an UHPLC-UV Method for Quantification of Three Phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates in CD-1® IGS Female Mouse Plasma

  • ARTICLES
  • Published:
Journal of Analytical Chemistry Aims and scope Submit manuscript

Abstract

Phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates (PAIB-SOs) are new antimitotic prodrugs bioactivated by the enzyme CYP1A1 into phenyl 4-(2-oxo-3-imidazolidin-1-yl)benzenesulfonates (PIB-SOs) that are potently (nM) and selectively inhibiting the growth of CYP1A1-expressing breast cancer cells. The screening program identified three PAIB-SOs designated as CEU-835, CEU-934, and CEU-938 for further pharmacokinetic studies. A novel method for their quantification in CD-1® IGS female mouse plasma using a Waters UHPLC ACQUITY Arc system was developed and validated. Their analytical measurements ranged from 7.3 to 1484 ng/mL. They exhibited linearity between 7.3 and 1484 ng/mL. They also showed good resolutions (2.21–4.99) and good theoretical plate numbers (14707–70580). Moreover, they were robust at wavelengths between 273 and 310 nm and sensitive from 2 to 62 AU/ng mL−1. This new method is indispensable to assess PAIB-SOs half-life in mouse plasma and for the quantification of PAIB-SOs in other biological matrices.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

REFERENCES

  1. Smolarz, B., Nowak, A.Z., and Romanowicz, H., Cancers, 2022, vol. 14, no. 10, p. 2569.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Fortin, S., Charest-Morin, X., Turcotte, V., Lauvaux, C., Lacroix, J., Cote, M.-F., Gobeil, S., and C.-Gaudreault, R., J. Med. Chem., 2017, vol. 60, no. 12, p. 4963.

    Article  CAS  PubMed  Google Scholar 

  3. Zarifi Khosroshahi, M., Chavez Alvarez, A.C., Gagne-Boulet, M., C.-Gaudreault, R., Gobeil, S., and Fortin, S., J. Pharm. Pharmacol., 2020, vol. 72, no. 2, p. 249.

    Article  CAS  PubMed  Google Scholar 

  4. Bouzriba, C., Chavez Alvarez, A.C., Gagne-Boulet, M., Ouellette, V., Lacroix, J., Côté, M.-F., C.-Gaudreault, R., and Fortin, S., Eur. J. Med. Chem., 2021, vol. 229, p. 114003.

    Article  PubMed  Google Scholar 

  5. Chavez Alvarez, A.C., Bouzriba, C., Moreau, E., Auzeloux, P., Besse, S., Ouellette, V., Zarifi Khosroshahi, M., Côté, M.-F., Pilote, S., Miot-Noirault, E., Chezal, J.-M., Simard, C., C.-Gaudreault, R., and Fortin, S., J. Med. Chem., 2023, vol. 66, no. 4, p. 2477.

    Article  CAS  PubMed  Google Scholar 

  6. Fortin, S., Wei, L., Moreau, E., Lacroix, J., Côté, M.F., Petitclerc, E., P. Kotra, L., and C.-Gaudreault, R., Eur. J. Med. Chem., 2011, vol. 46, no. 11, p. 5327.

    Article  CAS  PubMed  Google Scholar 

  7. Fortin, S., Wei, L., Moreau, E., Lacroix, J., Côté, M.-F., Petitclerc, E., P. Kotra, L., and C.-Gaudreault, R., J. Med. Chem., 2011, vol. 54, no. 13, p. 4559.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Panchagnula, R. and Thomas, N.S., Int. J. Pharm., 2000, vol. 201, no. 2, p. 131.

    Article  CAS  PubMed  Google Scholar 

  9. Jang, G.R., Harris, R.Z., and Lau, D.T., Med. Res. Rev., 2001, vol. 21, no. 5, p. 382.

    Article  CAS  PubMed  Google Scholar 

  10. Manikandan, S., J. Pharmacol. Pharmacother., 2011, vol. 2, no. 2, p. 140.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Lee, D.K., In, J., and Lee, S., Korean J. Anesthesiol., 2015, vol. 68, no. 3, p. 220.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Taylor, J.K., Anal. Chem., 1981, vol. 53, no. 14, p. 1588A.

    Article  CAS  Google Scholar 

  13. Papadoyannis, I.N. and Samanidou, V.F., J. Liq. Chromatogr. Relat. Technol., 2004, vol. 27, no. 5, p. 753.

    Article  CAS  Google Scholar 

  14. Doran, P.M., Unit operations, in Bioprocess Engineering Principles, Doran, P.M., Ed., London: Academic, 1995, p. 218.

    Google Scholar 

Download references

ACKNOWLEDGEMENTS

The authors would like to thank Dr. Alexandre Patenaude for his assistance in the correction of the manuscript.

Funding

This research was supported by grants from Fonds de Recherche du Québec-Santé (FRQ-S), research infrastructure program of John R. Evans Leaders Fund from Canada Foundation for Innovation (CFI, Canada, grant No. 36231), Fonds d’enseignement et de recherche of the Faculté de pharmacie de l’Université Laval, Réseau québécois de recherche sur les médicaments (RQRM) and Canadian Institutes of Health Research (PJT-178096). A.C. Chavez Alvarez, C. Bouzriba, V. Ouellette and M. Gagné-Boulet are recipients of studentships from the Fonds d’enseignement et de recherche of the Faculté de pharmacie de l’Université Laval and FRQ-S. S. Fortin is the recipient of a Junior 2 research scholar award from FRQ-S.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Atziri Corin Chavez Alvarez or Sébastien Fortin.

Ethics declarations

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

Animal-related experiments were conducted in accordance with the Conseil canadien de protection des animaux (CCPA) and the Comité de protection des animaux de l’Université Laval (CPAUL) and its guidelines (https://www.services-recherche.ulaval.ca/conduite-responsable-et-ethique/protection-des-animaux). Animal protocols were approved by the CPAUL, Université Laval, Québec, Canada (Approval IDs 2018-014-1 and 2018-014-2).

CONFLICT OF INTEREST

The authors of this work declare that they have no conflicts of interest.

Additional information

Publisher’s Note.

Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alvarez, A., Bouzriba, C., Bernier, L. et al. Development of an UHPLC-UV Method for Quantification of Three Phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates in CD-1® IGS Female Mouse Plasma. J Anal Chem 79, 456–463 (2024). https://doi.org/10.1134/S1061934824040026

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1061934824040026

Keywords:

Navigation